Refreshing results…
Venetoclax and idasanutlin in relapsed/refractory AML: a nonrandomized, open-label phase 1b trial
UploadPersonalized Prediction Model to Risk Stratify Patients With Myelodysplastic Syndromes
Download from doi.orgEprenetapopt (APR-246) and Azacitidine in TP53-Mutant Myelodysplastic Syndromes
Download from doi.orgBCL6 maintains survival and self-renewal of primary human acute myeloid leukemia cells
Download from ashpublications.orgMissing publications? Search for publications with a matching author name.